STEVE ASELAGE

Insider Reports History

Location
Fremont, CA
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by STEVE ASELAGE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. Director Common Stock 146,919 $1,316,394 $8.96 11 May 2022 Direct
Acer Therapeutics Inc. Director Common Stock 483,741 $590,164 $1.22 29 Nov 2022 Direct
BIOCRYST PHARMACEUTICALS INC Director Common Stock 70,159 $453,227 $6.46 12 Jun 2024 Direct
BIOCRYST PHARMACEUTICALS INC Director Common Stock 2,500 $16,150 $6.46 12 Jun 2024 By Trust
Travere Therapeutics, Inc. Director Employee stock option (right to buy) 70,000 05 Nov 2021 Direct
BIOCRYST PHARMACEUTICALS INC Director Automatic Stock Option Grant 49,933 12 Jun 2024 Direct
Acer Therapeutics Inc. Director Stock Option (right to buy) 20,000 14 Mar 2023 Direct
Acer Therapeutics Inc. Director Common Stock, $0.0001 par value per share 0 17 Nov 2023 Direct

Insider Reports Filed by STEVE ASELAGE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCRX BIOCRYST PHARMACEUTICALS INC 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:20
BCRX BIOCRYST PHARMACEUTICALS INC 24 May 2024 1 +$16,000 4 Director 29 May 2024, 16:16
/report/000089924323020445-aselage-steve-2023-11-17 Acer Therapeutics Inc. 17 Nov 2023 1 $0 4 Director 20 Nov 2023, 17:09
BCRX BIOCRYST PHARMACEUTICALS INC 13 Jun 2023 2 $0 4 Director 15 Jun 2023, 16:39
/report/000120919123019300-aselage-steve-2023-03-14 Acer Therapeutics Inc. 14 Mar 2023 1 $0 4 Director 16 Mar 2023, 16:30
/report/000120919122059172-aselage-steve-2022-11-29 Acer Therapeutics Inc. 29 Nov 2022 1 +$500,000 4 Director 01 Dec 2022, 15:01
BCRX BIOCRYST PHARMACEUTICALS INC 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 16:36
BCRX BIOCRYST PHARMACEUTICALS INC 31 May 2022 1 +$5,297 4 Director 02 Jun 2022, 16:43
TVTX Travere Therapeutics, Inc. 11 May 2022 1 -$56,457 4 Director 12 May 2022, 20:35
BCRX BIOCRYST PHARMACEUTICALS INC 28 Feb 2022 1 +$5,000 4 Director 02 Mar 2022, 15:34
/report/000120919122003708-aselage-steve-2022-01-14 Acer Therapeutics Inc. 14 Jan 2022 1 $0 4 Director 19 Jan 2022, 15:15
/report/000120919121069227-aselage-steve-2021-12-09 Acer Therapeutics Inc. 09 Dec 2021 2 +$20,622 4 Director 13 Dec 2021, 15:02
BCRX BIOCRYST PHARMACEUTICALS INC 30 Nov 2021 1 +$4,993 4 Director 02 Dec 2021, 15:15
TVTX Travere Therapeutics, Inc. 16 Nov 2021 1 -$934,602 4 Director 18 Nov 2021, 15:08
TVTX Travere Therapeutics, Inc. 05 Nov 2021 3 -$100,000 4 Director 09 Nov 2021, 15:05
TVTX Travere Therapeutics, Inc. 01 Nov 2021 6 -$252,400 4 Director 03 Nov 2021, 16:05
TVTX Travere Therapeutics, Inc. 07 Oct 2021 4 -$600,960 4 Director 08 Oct 2021, 16:18
BCRX BIOCRYST PHARMACEUTICALS INC 31 Aug 2021 1 +$4,999 4 Director 02 Sep 2021, 16:28
BCRX BIOCRYST PHARMACEUTICALS INC 28 May 2021 1 +$9,998 4 Director 01 Jun 2021, 16:16
BCRX BIOCRYST PHARMACEUTICALS INC 25 May 2021 1 $0 4 Director 27 May 2021, 16:16
TVTX Travere Therapeutics, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 21:21
TVTX Travere Therapeutics, Inc. 11 May 2021 1 -$42,023 4 Director 13 May 2021, 16:05